Search Medical Condition
Please enter condition
Please choose location
 

TBD, Turkey Clinical Trials

A listing of TBD, Turkey clinical trials actively recruiting patients volunteers.

RESULTS

Found (55338) clinical trials

People with Delayed Graft Function are asked to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

People with esophageal cancer are asked to participate in a research study being conducted by North Shore University Hospital.

Phase N/A

The primary objective of this study is to obtain de-identified, clinically characterized, whole blood specimens for use in assessing new biomarkers for the detection of neoplasms of the lung.

Phase N/A

The EXPLORE study will observe the safety and effectiveness of using the medication lesinurad in combination with a xanthine oxidase inhibitor (XOI), compared to using an XOI alone, to lower uric acid levels in the blood of adult patients with gout and kidney disease.

Phase

ICON Early Phase Services is conducting a research study for adults with type 2 diabetes taking insulin, ages 45-70. This study is being done to gather data. The data will be used to create a glycemic model of a type 2 diabetic subject to enable future insulin dosing recommendations.  There ...

Phase

To evaluate the effect of treatment with omecamtiv mecarbil (OM) compared with placebo on the time to cardiovascular (CV) death or first HF (Heart Failure) event, whichever occurs first, in subjects with chronic HF with reduced ejection fraction (HFrEF) receiving standard of care (SoC) therapy.

Phase N/A

To assess the effect of 3 doses of GP MDI compared to Placebo MDI and Spiriva® Respimat® on lung function over 24 weeks in subjects with persistent asthma. 

Phase N/A

To compare overall survival (OS) of patients with metastatic pancreatic adenocarcinoma (PDAC) treated with BBI-608 plus weekly nab-paclitaxel with gemcitabine (Arm 1) versus weekly nab-paclitaxel with gemcitabine (Arm 2).

Phase N/A

The primary objective of this trial is to demonstrate the superior efficacy of AMPHORA compared to placebo for the prevention of urogenital CT infection. The primary efficacy endpoint is the proportion of subjects who experience at least one CT infection during the study intervention period (incident infection of CT). 

Phase N/A

To estimate the PFS of ABT-165 plus irinotecan, fluorouracil and leucovorin chemotherapy regimen (FOLFIRI) compared to bevacizumab plus FOLFIRI, as assessed by blinded independent central review, in subjects with previously treated mCRC who have received a regimen containing fluoropyrimidine, oxaliplatin, and bevacizumab.  

Phase N/A